MedTrace Logo

Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis:

NCT06043544 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-09-21

No results posted yet for this study

Summary

This monocentric randomized open-label study aims to assess the efficacy and safety of a treatment with medium molecular weight hyaluronic acid (HA) compared to a treatment with corticosteroids on patients affected by glenohumeral osteoarthritis.

Conditions

  • Glenohumeral Osteoarthritis

Interventions

DEVICE

Hyaluronic Acid 24 MG in 3 mL Prefilled Syringe

Patients in the treatment group received two intra-articular injections with Hymovis® (24mg/3ml) a week apart from each other

DRUG

Corticosteroid injection

Patients in control group received two intra-articular injections with corticosteroids a week apart from each other.

Sponsors & Collaborators

  • Concordia Hospital Rome

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-02
Primary Completion
2021-11-10
Completion
2022-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06043544 on ClinicalTrials.gov